Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-003013-41-DK
EUCTR2006-003013-41-DK
Active, Not Recruiting
Phase 1

Short-term and longterm growth in children with asthma treated with budesonide or montelukast

Children's Clinic Randers0 sites60 target enrollmentJune 29, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsPulairmaxSingulair

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Children's Clinic Randers
Enrollment
60
Status
Active, Not Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 29, 2006
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Children's Clinic Randers

Eligibility Criteria

Inclusion Criteria

  • •prepubertal
  • •normal weight and height
  • •informed consent
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) no
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •concurrent treatment with glucocorticoids (other than investigational product)
  • •major surgery within 4 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
N/A
Growth Retardation in Children With Special Pathological Conditions or DiseaseGrowth Disorders, Growth RetardationTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2004-002991-40-Outside-EU/EEAPfizer Inc46
Active, Not Recruiting
N/A
EVOLUTION OF GROWTH RATE IN CHILDRE N WITH GROWTH RETARDATION RELATED TO LONG-TERM GLUCOCORTICOSTEROID THERAPY AND TREATED BY GENOTONORM®Growth retardation related to long-term glucocorticoid therapyMedDRA version: 18.0Level: PTClassification code 10053759Term: Growth retardationSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Hormonal diseases [C19]
EUCTR2004-002992-17-Outside-EU/EEAPfizer, Inc.98
Completed
N/A
Growth and Neurodevelopment Outcome of IUGR preterm infants (<35 weeks) with abnormal doppler studies at 1 year of corrected age
CTRI/2009/091/000509one300
Completed
N/A
Growth and development of the term infants with apnea in otherwise healthy: A prospective observational studyApnea in the otherwise healthy, term infants
JPRN-UMIN000045589ational Hospital Organization Miyakonojo Medical Center20
Unknown
Phase 3
clinical trial comparing the long term outcomes of post discharge probiotic treatment in moderately premature infants
CTRI/2017/12/011033Surya Childrens Medicare Pvt Ltd